Network origin in Catherine Hu first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 15 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Catherine Hu via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Scholar Rock, Inc.
 Scholar Rock, Inc. BiotechnologyHealth Technology Scholar Rock, Inc. operates as a biotechnology company. It focuses on discovering and developing a novel class of biologic therapies that target supracellular activation of growth factors in the disease microenvironment. The company was founded by Timothy Springer and Leonard Zon and is headquartered in Cambridge, MA. | Biotechnology | Founder Director of Finance/CFO Chief Executive Officer Chief Executive Officer Director/Board Member Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal General Counsel Human Resources Officer | |
| ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| F.W. Olin Graduate School of Business | College/University | Masters Business Admin Masters Business Admin | |
| ALAUNOS THERAPEUTICS, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| EDITAS MEDICINE, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| Bentley University | College/University | Graduate Degree Graduate Degree | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Graduate Degree | |
| Karolinska Institutet | College/University | Corporate Officer/Principal | |
| IRONWOOD PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Comptroller/Controller/Auditor | |
Holy Name Medical Center, Inc.
 Holy Name Medical Center, Inc. Hospital/Nursing ManagementHealth Services Holy Name Hospital provides healthcare services. It offers angioplasty, bariatric, cancer, genetic testing and laboratory services. The company was founded by Frank McCormack, George P. Pitkin and Agatha Brown in 1925 and is headquartered in Teaneck, NJ. | Hospital/Nursing Management | Human Resources Officer | |
| HONEYWELL INTERNATIONAL INC. | Aerospace & Defense | Corporate Officer/Principal | |
| Seton Hall University | College/University | Graduate Degree | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Human Resources Officer | |
Hemab Therapeutics ApS
 Hemab Therapeutics ApS BiotechnologyHealth Technology Hemab Therapeutics ApS is a clinical-stage biotech company based in Copenhagen, Denmark and MA. The Danish company is focused on developing novel prophylactic therapeutics for serious, underserved bleeding and thrombotic disorders. Hemab is progressing a pipeline of monoclonal and bispecific antibody-based therapeutics to transform the treatment paradigm for patients with high unmet need. The company's strategic guidance, Hemab 1-2-5tm, targets the development of 5 independent assets by 2025 to deliver long-awaited innovation for patients with high unmet need blood-clotting disorders like Glanzmann thrombasthenia, Factor VII deficiency, Bernard Soulier syndrome, von Willebrand disease, and other serious disorders. | Biotechnology | Director/Board Member | |
| University of Cardiff | College/University | Undergraduate Degree | |
| VISTERRA INC | Pharmaceuticals: Major | Director/Board Member | |
| Cardiff University School of Medicine | College/University | Doctorate Degree | |
| The Royal College of Physicians | College/University | Corporate Officer/Principal | |
| Clark University | College/University | Undergraduate Degree | |
| University of London | College/University | Doctorate Degree | |
Abata Therapeutics, Inc.
 Abata Therapeutics, Inc. BiotechnologyHealth Technology Abata Therapeutics, Inc. is a biotech company based in Watertown, MA. Abata Therapeutics is focused on developing engineered Treg cell therapies for severe autoimmune and inflammatory diseases. The American company's lead programs are in ind-enabling studies for progressive multiple sclerosis and type 1 diabetes, both of which are tissue-specific autoimmune diseases with significant unmet needs. The company has developed a differentiated product engine to create tissue-specific, robust, and durable therapies. Abata Therapeutics was launched by Third Rock Ventures, with participation from a diverse syndicate of investors, including ElevateBio, Lightspeed Venture Partners, Invus, Samsara Biocapital, and the JDRF T1D Fund. The company was founded in 2021 by Richard Ransohoff and the CEO is Samantha Singer. | Biotechnology | Director/Board Member | |
Kojin Therapeutics, Inc.
 Kojin Therapeutics, Inc. BiotechnologyHealth Technology Kojin Therapeutics, Inc. operates as a small-molecule therapeutics company. It focuses on translating deep biological insight into the plasticity of human cell states to develop therapeutics for cancer, fibrosis, ischemia and immune modulation. The company was founded by Benjamin Cravatt, Stephanie K. Dougan and Stuart L.Schreiber and is headquartered in the United States. | Biotechnology | Director/Board Member | |
| SYNLOGIC, INC. | Biotechnology | Comptroller/Controller/Auditor | |
Exo Therapeutics, Inc.
 Exo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Exo Therapeutics, Inc. engages in production of drugs. It has developed a small-molecule enzyme inhibitor discovery platform that targets distal binding pockets of enzymes (exo-sites) that are not evolutionarily conserved. The company was founded by David R. Liu and Alan Saghatelian and is headquartered in Boston, MA. | Pharmaceuticals: Major | Chairman | |
Casma Therapeutics, Inc.
 Casma Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Casma Therapeutics, Inc. operates biotechnology company harnessing natural cellular process of autophagy to design new medicines. The company was founded by Cary Pfeffer and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member | |
Camena Bioscience Ltd.
 Camena Bioscience Ltd. BiotechnologyHealth Technology Camena Bioscience Ltd. is a British biotechnology company that produces long and complex synthetic genes. The company is based in Cambridge, UK. Camena Bioscience was founded in 2016 by Steve Harvey. Steve Harvey has been the CEO since 2016. | Biotechnology | Director/Board Member | |
| ABIOMED, INC. | Medical Specialties | Comptroller/Controller/Auditor | |
TwistDx Ltd.
 TwistDx Ltd. BiotechnologyHealth Technology Part of Abbott Laboratories, TwistDx Ltd. is a British company that specializes in recombinase polymerase amplification technology. The company is based in Maidenhead, UK. The company offers TwistAmp research kits for researchers to develop tests, assays, and kits relevant to their work in fields such as water testing, biodefense, food species verification, and clinical or veterinary diagnostics. The company can work with partners on specific assay development collaborations for research and commercial applications. The company offers devices and accessories for research and development use only. The company was founded in 2002 by Niall Armes, Derek Stemple, Nagesh K. Mahanthappa. | Biotechnology | Founder | |
TwistDX, Inc.
 TwistDX, Inc. Miscellaneous Commercial ServicesCommercial Services TwistDX, Inc. provides scientific research and development services. The private company is based in Cambridge, MA. The company was founded by Nagesh K. Mahanthappa. | Miscellaneous Commercial Services | Founder | |
| Le Moyne College | College/University | Undergraduate Degree | |
Wellington Management Co. LLP
 Wellington Management Co. LLP Investment ManagersFinance Wellington Management Co. LLP (WMC) is a SEC-registered investment advisor and mutual fund manager headquartered in Boston, Massachusetts. The firm was founded in 1928 and is a subsidiary of Wellington Investment Advisors Holdings LLP, ultimately held by Wellington Management Group LLP. WMC offers investment management services for a fee to separate account clients and mutual funds sponsored by unaffiliated parties, and to investment vehicles that the firm sponsors. | Investment Managers | Comptroller/Controller/Auditor | |
| LIPOCINE INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| ALKERMES PLC | Pharmaceuticals: Major | General Counsel | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of British Columbia | College/University | Doctorate Degree | |
| National & Kapodistrian University of Athens | College/University | Doctorate Degree | |
Cystic Fibrosis Foundation
 Cystic Fibrosis Foundation Medical/Nursing ServicesHealth Services Cystic Fibrosis Foundation is a donor-supported non-profit organization which focuses in the search for a cure for cystic fibrosis. The foundation funds cystic fibrosis research. It also supports and accredits a national care center network recognized by the National Institutes f Health as a model of care for a chronic disease. The company was founded in 1955 and is headquartered in Bethesda, MD. | Medical/Nursing Services | Director/Board Member | |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor | |
Septerna, Inc.
 Septerna, Inc. Pharmaceuticals: MajorHealth Technology Septerna, Inc. is a biotechnology company located in an undisclosed location. The American company is focused on developing novel, oral small molecule drugs that target the entire class of G protein-coupled receptors (GPCRs). The company's Native Complex™ platform allows for the rapid application of new technologies for industrial-scale drug discovery to address both validated GPCRs and many GPCRs that have been undruggable and unexploited to date. Septerna is building a pipeline of GPCR-targeted, oral small molecule drug candidates, led by its program targeting the parathyroid hormone 1 receptor (PTH1R) for the treatment of hypoparathyroidism. The company was founded in 2022 by scientific founders who have made groundbreaking GPCR discoveries, including Patrick Sexton, Arthur Christopoulos, Robert Joseph Lefkowitz, and Jeffrey T. Finer. Jeffrey T. Finer has been the CEO since incorporation. | Pharmaceuticals: Major | Chief Operating Officer | |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Bard College | College/University | Undergraduate Degree | |
| State University of New York at Albany | College/University | Undergraduate Degree | |
| Massachusetts College of Pharmacy & Health Science | College/University | Graduate Degree |
Statistics
International
| United States | 38 |
| United Kingdom | 7 |
| Canada | 3 |
| Sweden | 2 |
| Denmark | 2 |
Sectoral
| Health Technology | 26 |
| Consumer Services | 18 |
| Health Services | 3 |
| Commercial Services | 3 |
| Finance | 3 |
Operational
| Director/Board Member | 46 |
| Corporate Officer/Principal | 41 |
| Independent Dir/Board Member | 17 |
| Undergraduate Degree | 14 |
| Director of Finance/CFO | 13 |
Most connected contacts
| Insiders | |
|---|---|
| Timothy Springer | 19 |
| Nagesh Mahanthappa | 19 |
| Elan Ezickson | 17 |
| Edward Myles | 16 |
| Tony Kingsley | 14 |
| Akshay Vaishnaw | 11 |
| George G Nomikos | 8 |
| Erin Moore | 8 |
| Rhonda Chicko | 7 |
| Joshua Reed | 7 |
| Dodzie Sogah | 7 |
| Caryn Parlavecchio | 6 |
| Jun Lin Ho | 6 |
| Heather Faulds | 6 |
| Lisa Amaya Price | 5 |
- Stock Market
- Insiders
- Catherine Hu
- Company connections
